Literature DB >> 30090930

Randomized Trial Needed to Confirm Whether Dalcetrapib Improves Outcomes for Specific ADCY9 Genotype-Reply.

Steven E Nissen1, Sreekumar G Pillai2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30090930     DOI： 10.1001/jamacardio.2018.2382

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  1 in total

1.  Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome.

Authors:  Yueheng Wu; Yu Xia; Ping Li; Hui-Qi Qu; Yichuan Liu; Yongchao Yang; Jijin Lin; Meng Zheng; Lifeng Tian; Zhuanbin Wu; Shufang Huang; Xianyu Qin; Xianwu Zhou; Shaoxian Chen; Yanying Liu; Yonghua Wang; Xiaofeng Li; Hanshi Zeng; Hakon Hakonarson; Jian Zhuang
Journal:  Orphanet J Rare Dis       Date:  2020-04-22       Impact factor: 4.123
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.